Clerio Vision, Inc.:
Novel ophthalmic technology to treat refractive error addressing multi-billion contact lens and corneal vision correction markets. Based on Nobel Prize winning femto-second laser technology developed by Bausch & Lomb and the University of Rochester. Contact lens approval expected mid-2022, clinical studies ongoing for presbyopia, hyperopia and myopia. Recently signed $1B silicon hydrogel contact lens partnership with a leading eye care company. Clerio's non-surgical flapless corneal vision correction solution expected to unlock LASIK market opportunity. $70M raised to date.
US - Middle Atlantic
Medical Device, Medical Technology
Under the Radar
1892 S. Winton Rd.
Rochester, NY 14618
Upcoming Company Event Participation